Shukla SD and Hanahan DJ |
An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). |
1983 |
Arch. Biochem. Biophys. |
pmid:6320731
|
Larsen GL and Henson PM |
Mediators of inflammation. |
1983 |
Annu. Rev. Immunol. |
pmid:6399978
|
Albert DH and Snyder F |
Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. |
1983 |
J. Biol. Chem. |
pmid:6401298
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Drapier JC et al. |
Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants. |
1983 |
Biochim. Biophys. Acta |
pmid:6131693
|
Otsuka A et al. |
alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats. |
1983 |
Clin Exp Hypertens A |
pmid:6133661
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Haddad ZH and Green A |
State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators. |
1983 |
J Asthma |
pmid:6190793
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Farr RS et al. |
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. |
1983 |
Fed. Proc. |
pmid:6628702
|
Denjean A et al. |
Acute effects of intratracheal administration of platelet-activating factor in baboons. |
1983 |
J Appl Physiol Respir Environ Exerc Physiol |
pmid:6629917
|
Yamashita M et al. |
The metabolism of platelet activating factor in platelets and plasma of various animals. |
1983 |
J Toxicol Sci |
pmid:6663653
|
Masugi F et al. |
[Kidney medulla and hypertension, with special reference to antihypertensive lipids]. |
1983 |
Nihon Jinzo Gakkai Shi |
pmid:6663856
|
Tanaka S et al. |
Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs. |
1983 |
J. Pharmacobio-dyn. |
pmid:6668545
|
Saeki S et al. |
Hypotensive activity of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats with various types of hypertension. |
1983 |
Med J Osaka Univ |
pmid:6669136
|
Machin SJ et al. |
Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder. |
1983 |
J. Clin. Pathol. |
pmid:6413552
|
Alam I et al. |
Metabolism of platelet-activating factor by blood platelets and plasma. |
1983 |
Lipids |
pmid:6413803
|
Pinckard RN |
Platelet-activating factor. |
1983 |
Hosp. Pract. (Off. Ed.) |
pmid:6414941
|
Camussi G et al. |
The release of platelet-activating factor from human endothelial cells in culture. |
1983 |
J. Immunol. |
pmid:6415166
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|